The 2017 systematic review concluded that RIF improves OS/AOS status of patients with clinical conditions (e.g., hypertension, diabetes, polycystic ovary syndrome, cardiac or cerebrovascular diseases, metabolic syndrome, obesity; Shephard, 2017 ): among the 10 studies including patients with chronic diseases, 8 studies identified an improvement of OS status during RIF, one study ( n = 56 patients with stable cardiac disease) identified a nonsignificant trend to a decrease of CRP during RIF; and the other study ( n = 82 patients with coronary or cerebrovascular disease or metabolic syndrome) registered no change in either CRP or homocysteine concentrations.
← all excerpts
The Impacts of Ramadan Intermittent Fasting on Oxidant/Antioxidant Stress Biomarkers of Stable Chronic Obstructive Pulmonary Disease Male Patients.
1
—
—